United Kingdom

People: argenx SE (ARGX.OQ)

ARGX.OQ on NASDAQ Stock Exchange Global Select Market

5:05pm BST
Change (% chg)

$2.60 (+2.08%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Castaldi, Eric 

Mr. Eric Castaldi serves as Chief Financial Officer at argenx SE. He was Chief Financial Officer, Member of the Board from July 2014 until April 26, 2017. Mr. Castaldi has 28 years of international financial executive management experience, including 19 years in the biopharmaceutical industry. Before joining arGEN-X, Mr. Castaldi was CFO from 1998 to 2013 at Nicox, a Euronext-listed biotech company. At Nicox, he was a member of the Executive committee and participated in all the financings of the company since its IPO in November 1999. From 2008 to 2012 he also served as board member and chairman of the audit committee of Hybrigenics, a French biopharmaceutical company specialized in oncology and listed on Euronext. Prior to this he was CFO at Safety Kleen Corporation, a US-based environmental waste company, where he was responsible for operations in France and Belgium. From 1989 through 1997, he was CFO in charge of French and German operations, at My Kinda Town plc, a European leisure company. During that period, he was involved in the 1994 flotation of that company on the London Stock Exchange. From 1986 through 1989, he was employed as Financial Analyst at the Research and Development Centre, located in Sophia Antipolis, of Cordis Corporation, a US-based company specialized in bio-surgical instrumentation. He graduated in Finance, Accountancy and Administration from the University of Nice in 1986.

Basic Compensation

Total Annual Compensation, EUR 9,669,430
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 62,335
Fiscal Year Total, EUR 9,731,770

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --